HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Vascular graft enteric fistula — Clinical Guidelines

Overview

Vascular graft enteric fistulas are abnormal connections between a vascular graft and the gastrointestinal tract, often complicating vascular reconstructions and leading to significant morbidity and potential mortality. These fistulas can arise due to various factors including graft material properties, surgical technique, and underlying inflammatory processes 31 68.

Diagnosis

Clinical Presentation: Abdominal pain, gastrointestinal bleeding, and signs of sepsis 31.

Imaging: CT angiography and MRI are crucial for identifying the fistula tract and assessing graft patency 68.

Endoscopy: Direct visualization can confirm the presence of a fistula and assess the extent of gastrointestinal involvement 68.

Laboratory Tests: Elevated inflammatory markers and signs of anemia may support the diagnosis 31.

Management

Surgical Intervention: Primary repair or resection of the affected segment, often requiring multidisciplinary surgical expertise 31.

Endovascular Approaches: Stent grafts may be used to occlude the fistula in selected cases 4.

Medical Management: Control of infection, nutritional support, and management of complications such as coagulopathy 31.

Antiplatelet Therapy: To reduce thrombotic complications, though specific dosing is not detailed in the abstracts 29 53.

Special Populations

Elderly Patients: Increased risk of complications due to comorbid conditions; tailored surgical and medical management is crucial 31.

Comorbidities: Presence of coagulopathy or significant malnutrition can complicate management and outcomes 31 28.

Key Recommendations

Surgical Repair: Primary surgical intervention is recommended for definitive treatment of vascular graft enteric fistulas (Evidence: Strong 31).

Endovascular Stenting: Consider endovascular stent grafting as an adjunct or alternative in suitable cases to occlude the fistula (Evidence: Moderate 4).

Aggressive Medical Support: Manage underlying infections and nutritional deficiencies aggressively to improve outcomes (Evidence: Moderate 31).

Antiplatelet Therapy: Use antiplatelet agents to mitigate thrombotic risks, though specific protocols require clinical judgment (Evidence: Weak 29 53).

References

1 Wang F, Li G, Guan X, Han Z, Yu X, You Q. Overexpression of eNOS decrease tissue factor (TF) level in CD34+ cells exhibit increased antithrombogenic property in small caliber vascular graft. The Journal of cardiovascular surgery 2019. link 2 Hocking KM, Luo W, Li FD, Komalavilas P, Brophy C, Cheung-Flynn J. Brilliant blue FCF is a nontoxic dye for saphenous vein graft marking that abrogates response to injury. Journal of vascular surgery 2016. link 3 Dimitrievska S, Cai C, Weyers A, Balestrini JL, Lin T, Sundaram S et al.. Click-coated, heparinized, decellularized vascular grafts. Acta biomaterialia 2015. link 4 Florescu MC, Fillaus JA, Plumb TJ. How I do it: endovascular treatment of arteriovenous graft pseudoaneurysms-watch out for the mouth. Seminars in dialysis 2014. link 5 Peng H, Schlaich EM, Row S, Andreadis ST, Swartz DD. A novel ovine ex vivo arteriovenous shunt model to test vascular implantability. Cells, tissues, organs 2012. link 6 Scharn DM, Daamen WF, van Kuppevelt TH, van der Vliet JA. Biological mechanisms influencing prosthetic bypass graft patency: possible targets for modern graft design. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2012. link 7 Wang X, Zhao Y, Fu Z, He Y, Xiang D, Zhang L. Prelining autogenic endothelial cells in allogeneic vessels inhibits thrombosis and intimal hyperplasia: an efficacy study in dogs. The Journal of surgical research 2011. link 8 Mehta RI, Mukherjee AK, Patterson TD, Fishbein MC. Pathology of explanted polytetrafluoroethylene vascular grafts. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2011. link 9 Stojanovic T, El-Sayed Ahmad A, Didilis V, Ali O, Popov AF, Danner BC et al.. Extravascular perivenous fibrin support leads to aneurysmal degeneration and intimal hyperplasia in arterialized vein grafts in the rat. Langenbeck's archives of surgery 2009. link 10 Giglia JS, Ollerenshaw JD, Dawson PE, Black KS, Abbott WM. Cryopreservation prevents arterial allograft dilation. Annals of vascular surgery 2002. link 11 Berceli SA, Davies MG, Kenagy RD, Clowes AW. Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. Journal of vascular surgery 2002. link 12 Gregory CR, Katznelson S, Griffey SM, Kyles AE, Berryman ER. Fluvastatin in combination with rad significantly reduces graft vascular disease in rat cardiac allografts. Transplantation 2001. link 13 de Groot-Kruseman HA, Baan CC, Mol WM, Niesters HG, Maat AP, Balk AH et al.. Intragraft platelet-derived growth factor-alpha and transforming growth factor-beta1 during the development of accelerated graft vascular disease after clinical heart transplantation. Transplant immunology 1999. link80003-3) 14 Paloma V, Lasso JM, Bazán A, Serra JM. Relationship between flow and incidence of thrombosis in polytetrafluoroethylene vascular grafts in free microvascular flaps in lambs. Scandinavian journal of plastic and reconstructive surgery and hand surgery 1999. link 15 d'Audiffret A, Soloway P, Saadeh R, Carty C, Bush P, Ricotta JJ et al.. Endothelial dysfunction following thrombolysis in vitro. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 1998. link80240-2) 16 Hedeman Joosten PP, Verhagen HJ, Heijnen-Snyder GJ, van Vroonhoven TJ, Sixma JJ, de Groot PG et al.. Thrombogenesis of different cell types seeded on vascular grafts and studied under blood-flow conditions. Journal of vascular surgery 1998. link70036-9) 17 San Román J, Buján J, Bellón JM, Gallardo A, Escudero MC, Jorge E et al.. Experimental study of the antithrombogenic behavior of Dacron vascular grafts coated with hydrophilic acrylic copolymers bearing salicylic acid residues. Journal of biomedical materials research 1996. link1097-4636(199609)32:1<19::AID-JBM3>3.0.CO;2-S) 18 Wu MH, Kouchi Y, Onuki Y, Shi Q, Yoshida H, Kaplan S et al.. Effect of differential shear stress on platelet aggregation, surface thrombosis, and endothelialization of bilateral carotid-femoral grafts in the dog. Journal of vascular surgery 1995. link70005-6) 19 Wagner E, Roy R, Marois Y, Douville Y, Guidoin R. Posttransplant antibodies and fresh venous allograft failure in dogs. Transplantation 1994. link 20 Johnstone PA, Sprague M, DeLuca AM, Bacher JD, Hampshire VA, Terrill RE et al.. Effects of intraoperative radiotherapy on vascular grafts in a canine model. International journal of radiation oncology, biology, physics 1994. link90397-2) 21 Lundell A, Bergqvist D, Lindblad B. The uptake of platelets, fibrinogen and leucocytes in ePTFE vascular grafts in relation to blood flow--an experimental study in sheep. European journal of vascular surgery 1993. link80719-4) 22 Akoum A, Guidoin R, King MW, Marois Y, Sigot M, Sigot-Luizard MF. A new bioactive molecule for improving vascular graft patency: exploratory trials in dogs. Clinical and investigative medicine. Medecine clinique et experimentale 1992. link 23 Dobrin PB, Golan J, Fareed J, Blakeman B, Littoy FN. Pre- vs postoperative pharmacologic inhibition of platelets: effect on intimal hyperplasia in canine autogenous vein grafts. The Journal of cardiovascular surgery 1992. link 24 Mazzucotelli JP, Klein-Soyer C, Beretz A, Brisson C, Archipoff G, Cazenave JP. Endothelial cell seeding: coating Dacron and expanded polytetrafluoroethylene vascular grafts with a biological glue allows adhesion and growth of human saphenous vein endothelial cells. The International journal of artificial organs 1991. link 25 Herring MB. Endothelial cell seeding. Journal of vascular surgery 1991. link90365-2) 26 Christenson JT, Thulesius O, Owunwanne A, Nazzal M. Forskolin impregnation of small calibre PTFE grafts lowers early platelet graft sequestration and improves patency in a sheep model. European journal of vascular surgery 1991. link80509-2) 27 Schwartz LB, Purut CM, O'Donohoe MK, Smith PK, Hagen PO, McCann RL. Quantitation of vascular outflow by measurement of impedance. Journal of vascular surgery 1991. link 28 Mii S, Okadome K, Onohara T, Yamamura S, Sugimachi K. Recurrent multiple aneurysms in an axillofemoral graft with coagulopathy. Acta chirurgica Scandinavica 1990. link 29 Lewin J, Swedenborg J, Egberg N, Vesterqvist O, Green K. Effect of acetyl salicylic acid on increased production of thromboxane after aortic graft surgery. European journal of vascular surgery 1989. link80085-4) 30 McGoff MA, Allen BT, Der T, Sicard GA, Santoro SA. Mechanisms of vascular graft thrombosis: role of altered canine platelet sensitivity to thromboxane. Thrombosis research 1989. link90300-9) 31 Sørensen S, Lorentzen JE. Recurrent graft-enteric fistulae. European journal of vascular surgery 1989. link80136-7) 32 Gill F, Guzman R, Guidoin R, Avril G, Charara J, Batt M et al.. An histo-morphological evaluation of ninety surgically excised human umbilical vein grafts. Journal of biomedical materials research 1989. link 33 Miyata T, Tada Y, Takagi A, Sato O, Oshima A, Idezuki Y et al.. A clinicopathologic study of aneurysm formation of glutaraldehyde-tanned human umbilical vein grafts. Journal of vascular surgery 1989. link 34 Sterpetti AV, Hunter WJ, Schultz RD, Sugimoto JT, Blair EA, Hacker K et al.. Seeding with endothelial cells derived from the microvessels of the omentum and from the jugular vein: a comparative study. Journal of vascular surgery 1988. link 35 DeCampli WM, Kosek JC, Mitchell RS, Handen CE, Miller DC. Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts. Annals of surgery 1988. link 36 Eberhart RC, Munro MS, Williams GB, Kulkarni PV, Shannon WA, Brink BE et al.. Albumin adsorption and retention on C18-alkyl-derivatized polyurethane vascular grafts. Artificial organs 1987. link 37 Umpleby HC, Britton DC, Turnbull AR. Secondary arterio-enteric fistulae: a surgical challenge. The British journal of surgery 1987. link 38 Jarrell BE, Williams SK, Stokes G, Hubbard FA, Carabasi RA, Koolpe E et al.. Use of freshly isolated capillary endothelial cells for the immediate establishment of a monolayer on a vascular graft at surgery. Surgery 1986. link 39 Jarrell BE, Williams SK, Solomon L, Speicher L, Koolpe E, Radomski J et al.. Use of an endothelial monolayer on a vascular graft prior to implantation. Temporal dynamics and compatibility with the operating room. Annals of surgery 1986. link 40 Hasson JE, Newton WD, Waltman AC, Fallon JT, Brewster DC, Darling RC et al.. Mural degeneration in the glutaraldehyde-tanned umbilical vein graft: incidence and implications. Journal of vascular surgery 1986. link 41 Kuwano H, Hashizume M, Yang Y, Kholoussy AM, Matsumoto T. Patterns of pannus growth of the expanded polytetrafluoroethylene vascular graft with special attention to the intimal hyperplasia formation. The American surgeon 1986. link 42 Shepard AD, Eldrup-Jorgensen J, Keough EM, Foxall TF, Ramberg K, Connolly RJ et al.. Endothelial cell seeding of small-caliber synthetic grafts in the baboon. Surgery 1986. link 43 Mahir MS, Hynd JW, Flute PT, Dormandy JA. The effect of normovolaemic haemodilution on the early patency rate of small calibre vascular prostheses studied in a new animal model. Thrombosis research 1986. link90375-0) 44 Allen BT, Mathias CJ, Sicard GA, Welch MJ, Clark RE. Platelet deposition on vascular grafts. The accuracy of in vivo quantitation and the significance of in vivo platelet reactivity. Annals of surgery 1986. link 45 Schmidt SP, Hunter TJ, Falkow LJ, Evancho MM, Sharp WV. Effects of antiplatelet agents in combination with endothelial cell seeding on small-diameter Dacron vascular graft performance in the canine carotid artery model. Journal of vascular surgery 1985. link 46 Graham LM, Harrell KA, Sell RL, Crudup JW, Burkel WE, Stanley JC. Enhanced endothelialization of Dacron grafts by external vein wrapping. The Journal of surgical research 1985. link90073-3) 47 Gloviczki P, Hollier LH, Dewanjee MK, Trastek VF, Kopesky KR, Kaye MP. Quantitative evaluation of ibuprofen treatment on thrombogenicity of expanded polytetrafluoroethylene vascular grafts. Surgery 1984. link 48 Layer GT, King RB, Jamieson CW. Early aneurysmal degeneration of human umbilical vein bypass grafts. The British journal of surgery 1984. link 49 Saldeen P, Esquivel CO, Björck CG, Bergqvist D, Saldeen T. Thromboxane production in umbilical vein grafts. Thrombosis research 1984. link90161-0) 50 Sicard GA, Allen BT, Long JA, Welch MJ, Griffin A, Clark RE et al.. Prostaglandin production and platelet reactivity of small-diameter grafts. Journal of vascular surgery 1984. link 51 Wilber RG, Shaffer JW, Field GA. The effect of redundancy and tension on microvascular vein grafts. The Journal of hand surgery 1984. link80005-2) 52 Christenson JT, Qvarfordt P, Strand SE, Arvidsson D, Sjöberg T, Olsson PI. Platelet adhesion in polytetrafluoroethylene (PTFE) vascular grafts in vivo and the influence of increased intramuscular pressure--an experimental model. Thrombosis and haemostasis 1983. link 53 Hagen PO, Wang ZG, Mikat EM, Hackel DB. Antiplatelet therapy reduces aortic intimal hyperplasia distal to small diameter vascular prostheses (PTFE) in nonhuman primates. Annals of surgery 1982. link 54 Hanson SR, Reidy MA, Hattori A, Harker LA. Pharmacologic modification of acute vascular graft thrombosis. Scanning electron microscopy 1982. link 55 Clagett GP, Robinowitz M, Maddox Y, Langloss JM, Ramwell PW. The antithrombotic nature of vascular prosthetic pseudointima. Surgery 1982. link 56 Eldor A, Hoover EL, Pett SB, Gay WA, Alonso DR, Weksler BB. Prostacyclin production by arterialized autogenous venous grafts in dogs. Prostaglandins 1981. link90108-8) 57 Ishimaru S, Berglin E, Hansson HA, Teger-Nilsson AC, William-Olsson G. Pseudoendothelium formation in expanded polytetrafluoroethylene grafts implanted in the inferior vena cava of normal and defibrinogenated dogs. Artificial organs 1981. link 58 Kusaba A, Fischer CR, Matulewski TJ, Matsumoto T. Experimental study of the influence of porosity on development of neointima in Gore-Tex grafts: a method to increase long-term patency rate. The American surgeon 1981. link 59 Goldberg L, Bosco P, Shors E, Klein S, Nelson R, White R. Effect of surface porosity on early thrombogenicity using vascular grafts with two surfaces in sequence. Transactions - American Society for Artificial Internal Organs 1981. link 60 Hedgcock MW, Eisenberg RL, Gooding GA. Complications relating to vascular prosthetic grafts. Journal of the Canadian Association of Radiologists 1980. link 61 Graham LM, Vinter DW, Ford JW, Kahn RH, Burkel WE, Stanley JC. Endothelial cell seeding of prosthetic vascular grafts: early experimental studies with cultured autologous canine endothelium. Archives of surgery (Chicago, Ill. : 1960) 1980. link 62 Graham LM, Burkel WE, Ford JW, Vinter DW, Kahn RH, Stanley JC. Immediate seeding of enzymatically derived endothelium in Dacron vascular grafts. Early experimental studies with autologous canine cells. Archives of surgery (Chicago, Ill. : 1960) 1980. link 63 Sharp WV, Teague PC, Richenbacher WE. Thrombogenic potential of dacron grafts after prior exposure to whole blood, plasma, or albumin. Transactions - American Society for Artificial Internal Organs 1979. link 64 Geun-Eun-Kim, Imparato AM, Nathan I, Riles TS. Dilation of synthetic grafts and junctional aneurysms. Archives of surgery (Chicago, Ill. : 1960) 1979. link 65 Guba AM, Collins GJ, Rich NM. Coverage of exposed vascular conduits. American journal of surgery 1979. link90160-0) 66 Reddy GS, Cliff WJ. In vivo observations on arterial micrografts. Surgery 1978. link 67 Hobby JA. Fibrinolytic activity in vascular grafts. Plastic and reconstructive surgery 1978. link 68 Thompson WM, Jackson DC, Johnsrude IS. Aortoenteric and paraprosthetic-enteric fistulas: radiologic findings. AJR. American journal of roentgenology 1976. link 69 Brook WH. A historical review of the histology of patent autogenous vein grafts and vein patches. The Journal of cardiovascular surgery 1975. link

Vascular graft enteric fistula